GOLDMAN SACHS GROUP INC - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is and the CUSIP is 29089QAB1. A total of 24 filers reported holding EMERGENT BIOSOLUTIONS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q2 2017$1,634,000
+256.0%
1,268,000
+238.1%
0.00%
Q3 2016$459,000
+18.0%
375,000
+9.0%
0.00%
Q2 2016$389,000
+301.0%
344,000
+358.7%
0.00%
Q1 2016$97,000
-80.8%
75,000
-79.5%
0.00%
Q4 2015$504,000
-76.7%
366,000
-80.4%
0.00%
-100.0%
Q1 2015$2,159,0001,868,0000.00%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q1 2015
NameSharesValueWeighting ↓
LINDEN ADVISORS LP 32,141,000$41,558,0001.75%
Wellesley Asset Management 10,859$14,049,0000.73%
Opera Trading Capital 2,300,000$2,904,0000.51%
SSI INVESTMENT MANAGEMENT LLC 4,300,000$5,543,0000.49%
WOLVERINE ASSET MANAGEMENT LLC 25,653,000$33,152,0000.42%
AQR Arbitrage LLC 29,400,000$38,036,0000.42%
Calamos Advisors LLC 35,781,000$46,261,0000.34%
CSS LLC/IL 2,500,000$3,228,0000.16%
ADVENT CAPITAL MANAGEMENT /DE/ 3,126,000$4,043,0000.08%
D. E. Shaw & Co., Inc. 22,500,000$29,107,0000.05%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders